FDA
-
-
-
-
-
-
-
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
-
-
-
-
-
-
-
Seres Therapeutics cuts workforce 25% as it seeks funding for drug study
-
-
-
-
-
-
-
Seres Therapeutics (MCRB) Presents Expanded SER-155 Exploratory Biomarker Data
-
-
-
-
-
-
-
Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025
-
-
-
-
-
-
-
Seres Therapeutics (MCRB) : FDA Grants Breakthrough Therapy Designation to SER-155 for Reduction of Bloodstream Infections in Adults Undergoing allo-HSCT
-
-
-
-
-
-
-
Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30
-
-
-
-
-
-
-
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

